Year archive

Kane Biotech Inc. — 2026 filings

All 19 regulatory filings released by Kane Biotech Inc. (KNE) in 2026, sourced directly from the official regulator.

19 Filings

2026 Period

2026 filings (19)

Filing	Released	Lang
Annual MD&A - English.pdf Management Reports	2026-04-25	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2026-04-25	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2026-04-25	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-04-25	English
Audited annual financial statements – English.pdf Regulatory Filings	2026-04-25	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2026-04-24	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2026-04-24	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2026-04-24	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2026-04-24	English
Interim MD&A - English.pdf Management Reports	2026-04-24	English
Interim MD&A - English.pdf Management Reports	2026-04-24	English
Interim financial statements/report – English.pdf Regulatory Filings	2026-04-24	English
Interim financial statements/report – English.pdf Audit Report / Information	2026-04-24	English
Interim financial statements/report – English.pdf Audit Report / Information	2026-04-24	English
News release - English.pdf Earnings Release FY 2025	2026-04-24	English
News release - English.pdf Earnings Release FY 2025	2026-04-24	English
News release - English.pdf Regulatory Filings	2026-04-16	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2026-04-13	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2026-04-13	English